Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase.

Teodoro JG, Parker AE, Zhu X, Green MR.

Science. 2006 Aug 18;313(5789):968-71.

2.
3.

Regulation of collagen-derived antiangiogenic factors by p53.

Assadian S, Teodoro JG.

Expert Opin Biol Ther. 2008 Jul;8(7):941-50. doi: 10.1517/14712598.8.7.941 . Review.

PMID:
18549324
4.

p53 inhibits angiogenesis by inducing the production of Arresten.

Assadian S, El-Assaad W, Wang XQ, Gannon PO, Barrès V, Latour M, Mes-Masson AM, Saad F, Sado Y, Dostie J, Teodoro JG.

Cancer Res. 2012 Mar 1;72(5):1270-9. doi: 10.1158/0008-5472.CAN-11-2348. Epub 2012 Jan 17.

5.

Collagen XVIII/endostatin structure and functional role in angiogenesis.

Zatterstrom UK, Felbor U, Fukai N, Olsen BR.

Cell Struct Funct. 2000 Apr;25(2):97-101. Review.

6.

Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.

Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.

Chin Med J (Engl). 2008 Nov 20;121(22):2324-30.

PMID:
19080341
7.

Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.

Fernando NT, Koch M, Rothrock C, Gollogly LK, D'Amore PA, Ryeom S, Yoon SS.

Clin Cancer Res. 2008 Mar 1;14(5):1529-39. doi: 10.1158/1078-0432.CCR-07-4126.

8.

Vascular basement membrane-derived multifunctional peptide, a novel inhibitor of angiogenesis and tumor growth.

Cao JG, Peng SP, Sun L, Li H, Wang L, Deng HW.

Acta Biochim Biophys Sin (Shanghai). 2006 Jul;38(7):514-21.

9.

Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes.

Wu P, Yonekura H, Li H, Nozaki I, Tomono Y, Naito I, Ninomiya Y, Yamamoto H.

Biochem Biophys Res Commun. 2001 Nov 16;288(5):1149-54.

PMID:
11700031
10.

Overexpression of ornithine decarboxylase enhances endothelial proliferation by suppressing endostatin expression.

Nemoto T, Hori H, Yoshimoto M, Seyama Y, Kubota S.

Blood. 2002 Feb 15;99(4):1478-81.

11.

Association of cathepsin E with tumor growth arrest through angiogenesis inhibition and enhanced immune responses.

Shin M, Kadowaki T, Iwata J, Kawakubo T, Yamaguchi N, Takii R, Tsukuba T, Yamamoto K.

Biol Chem. 2007 Nov;388(11):1173-81.

PMID:
17976010
12.

The role of collagen-derived proteolytic fragments in angiogenesis.

Marneros AG, Olsen BR.

Matrix Biol. 2001 Sep;20(5-6):337-45. Review.

PMID:
11566268
13.

Effect of p53 status on tumor response to antiangiogenic therapy.

Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS.

Science. 2002 Feb 22;295(5559):1526-8.

14.

Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.

Heljasvaara R, Nyberg P, Luostarinen J, Parikka M, Heikkilä P, Rehn M, Sorsa T, Salo T, Pihlajaniemi T.

Exp Cell Res. 2005 Jul 15;307(2):292-304.

PMID:
15950618
15.

Inhibition of angiogenesis and tumorigenesis, and induction of dormancy by p53 in a p53-null thyroid carcinoma cell line in vivo.

Nagayama Y, Shigematsu K, Namba H, Zeki K, Yamashita S, Niwa M.

Anticancer Res. 2000 Jul-Aug;20(4):2723-8.

PMID:
10953350
16.

Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.

Bouquet C, Lamandé N, Brand M, Gasc JM, Jullienne B, Faure G, Griscelli F, Opolon P, Connault E, Perricaudet M, Corvol P.

Mol Ther. 2006 Aug;14(2):175-82. Epub 2006 Apr 5.

17.

Endostatin signaling and regulation of endothelial cell-matrix interactions.

Wickström SA, Alitalo K, Keski-Oja J.

Adv Cancer Res. 2005;94:197-229. Review.

PMID:
16096002
18.

Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors.

Wang B, Sun J, Kitamoto S, Yang M, Grubb A, Chapman HA, Kalluri R, Shi GP.

J Biol Chem. 2006 Mar 3;281(9):6020-9. Epub 2005 Dec 19.

19.

Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression.

Hamano Y, Sugimoto H, Soubasakos MA, Kieran M, Olsen BR, Lawler J, Sudhakar A, Kalluri R.

Cancer Res. 2004 Mar 1;64(5):1570-4.

20.

Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.

Zhang X, Xu J, Lawler J, Terwilliger E, Parangi S.

Clin Cancer Res. 2007 Jul 1;13(13):3968-76.

Supplemental Content

Support Center